AzTrials
AzTrials

Cerebral Blood FlowNCT04585971

A Study on Hemodynamic Relationship Including Cerebral Blood Flow Using Phase Contrast and Signal Intensity Gradient of Brain Magnetic Resonance Imaging, and Carotid Doppler Ultrasound

An observational study of Cerebral Blood Flow, run by Chonbuk National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Cerebral blood flow measurement, which is applied to patients with cerebrovascular-related diseases, provides useful information about hemodynamic status. There was a method using Doppler ultrasound and phase contrast (PC) MRI, but it was not widely used in clinical practice due to limitations in reproducibility… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cerebral Blood Flow
What is being tested?
Signal intensity gradient
How many people
30 participants
Where
1 siteSouth Korea
Study dates
3 Sep 2020to 31 Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients admitted to the neurology department of a tertiary center

Who may be able to join

  • Patients 18 years of age or older who have been admitted to the neurology department due to a stroke, and those who have already performed brain magnetic resonance imaging
  • Among the patients (1) who underwent carotid artery Doppler ultrasound
  • Patients who fully understand the research objectives and procedures and wish to participate in clinical research voluntarily
  • If a patient is not fully understood due to a decrease in awareness or consciousness, the consent of the legal representative is required

Who cannot join

  • Patients whose extracranial artery occlusion or severe stenosis was confirmed in brain magnetic resonance images.
  • Those who judge that the subject is unsuitable for participation in clinical research due to other reasons.

Trial locations and contacts

1 site in 1 country.

Chan-Hyuk Lee, Prof. contact

+82-063-250-1590

bluewave0210@gmail.com

South Korea1 site, 1 recruiting
  • Jeonbuk National University Hospital

    Jeonju, Jeollabuk-do, 54907

    Chan-Hyuk Lee, Prof., +82-010-2822-9803, bluewave0210@gmail.com

    Recruiting

Other trials in South Korea

About this study

Cerebral blood flow measurement, which is applied to patients with cerebrovascular-related diseases, provides useful information about hemodynamic status. There was a method using Doppler ultrasound and phase contrast (PC) MRI, but it was not widely used in clinical practice due to limitations in reproducibility between examiners, complexity of procedure, and time-intensive protocol. We intend to measure cerebral blood flow through the signal-intensity gradient (SIG) technique using Time-of-Flight (TOF) of brain magnetic resonance imaging, which can compensate for the shortcomings of the existing research methods. In addition, by analyzing the correlation with the previous methods, Doppler ultrasound and PC MRI, we will evaluate the effectiveness of our new method.

Being tested
Signal intensity gradient
Keywords
Endothelial shear stress, signal-intensity gradient, phase contrast MRI, Time-of-Flight MRI, Carotid Doppler sonography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Signal intensity gradientDiagnostic test

    Also called Time-of-flight magnetic resonance imaging, Carotid Doppler sonography

    Signal intensity gradient:

    In time-of-flight (TOF) MRA, The signal intensities at the iso-point (Φa; signal intensity at position A [Xa] along the arterial contour line) and at the inner point (Φb; signal intensity at position B [Xb]) were calculated by using a trilinear interpolation algorithm based on the positions and signal intensities in the eight neighboring voxels. The signal intensities of TOF-MRA were normalized to eliminate the offset and scale effects across the MRA datasets of participants. For each iso-point (position A), the SIG was calculated from the difference in signal intensities between points A and B as follows:

    Scalar SIG, SI/mm = (Φb - Φa) / │Xb - Xa│ (1)

    Vector SIG, SI/mm = (Φb - Φa) n / │Xb - Xa│ (2)

Study groups in NCT04585971
Study groupRoleWhat they receive
SubjectsCerebral blood flow of a subject is measured using three methods in both common carotid and vertebral arteries. 1) Phase-contrast MR 2) Doppler sonography 3) Signal Intensity Gradient (SIG) To determine whether there is a correlation between the measured values, the correlation coefficient is calculated and analyzed.
Receives: Diagnostic Test: Signal intensity gradient

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cerebral blood flow correlation

    Cerebral blood flow correlation between 3 tests (SIG, PC MR, US)

    Measured: After completion of recruitment, average 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2020
  2. Study start3 Sep 2020
  3. Primary completion31 Jan 2021 (estimated)
  4. Study completion31 Jan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04585971
Sponsor's protocol ID
SIGBF
Status last verified
Oct 2020
First submitted
6 Oct 2020
Last updated
14 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Han KS, Lee SH, Ryu HU, Park SH, Chung GH, Cho YI, Jeong SK. Direct Assessment of Wall Shear Stress by Signal Intensity Gradient from Time-of-Flight Magnetic Resonance Angiography. Biomed Res Int. 2017;2017:7087086. doi: 10.1155/2017/7087086. Epub 2017 Aug 16.

    PubMed 28900625
  • Lee WJ, Jeong SK, Han KS, Lee SH, Ryu YJ, Sohn CH, Jung KH. Impact of Endothelial Shear Stress on the Bilateral Progression of Unilateral Moyamoya Disease. Stroke. 2020 Mar;51(3):775-783. doi: 10.1161/STROKEAHA.119.028117. Epub 2019 Dec 20.

    PubMed 31856692
  • Jeong SK, Lee JY, Rosenson RS. Association between Ischemic Stroke and Vascular Shear Stress in the Carotid Artery. J Clin Neurol. 2014 Apr;10(2):133-9. doi: 10.3988/jcn.2014.10.2.133. Epub 2014 Apr 23.

    PubMed 24829599
  • Lee CH, Lee SH, Kwak HS, Rosenson RS, Jeong SK, Jung KH. Arterial flow volume measurement using signal intensity gradient versus phase contrast. Sci Rep. 2025 Dec 29;15(1):44848. doi: 10.1038/s41598-025-28379-7.

    PubMed 41461703
  • Lee CH, Lee SH, Kwak HS, Kwak YG, Rosenson RS, Cho YI, Jeong SK. Validation of Signal Intensity Gradient from TOF-MRA for Wall Shear Stress by Phase-Contrast MR. J Imaging Inform Med. 2024 Jun;37(3):1248-1258. doi: 10.1007/s10278-024-00991-5. Epub 2024 Feb 8.

    PubMed 38332403

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Blood Flow, run by Chonbuk National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Chan-Hyuk Lee, Prof. (+82-063-250-1590, bluewave0210@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cerebral blood flow correlation (time frame: After completion of recruitment, average 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04585971, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in